Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical production and sales, construction, real estate development, and property management businesses in China and internationally. The company offers huasu west-ground iodine, fesser phenylcycline hydrochloride, bosu fuma acid bisolol, yuanji beni flat hydrochloric acid, naloxone hydrochloride, five plus biochemical, and aramol quramado tablets and capsules. It also provides mucous membrane repair and oral health care products, including toothpaste, mouthwash, spray, dental equipment, and other oral care products for ulcers, burns, mechanical damage, and postoperative repair; and fruit enzymes, imported fungella enzymes, functional probiotics, and soda and other edible grade raw materials. In addition, the company invests in software technology, communications and electronic engineering, biomedicine, and life sciences and other fields. Beijing Centergate Technologies (holding) Co., Ltd. was founded in 1999 and is based in Beijing, China.

Mr. Bin  Li

Vice President

Mr. Zhanjun  Hou

President & Non-Independent Director

Mr. Xuewu  Song

Vice President & Chief Financial Officer

Mr. Zhiyu  Huang

Vice President & Board Secretary

Ying  Huang

Accounting Officer

Name	Market cap
MIG Holdings S.A.	0M
Corem Property Group AB (publ)	0M
Cushman & Wakefield plc	0M
ISP Holdings Limited	0M
First Property Group plc	0M
Tokyo Tatemono Co., Ltd.	0M
RE/MAX Holdings, Inc.	0M
Man Sang International Limited	0M
Pioneer Global Group Limited	0M
Fletcher King Plc	0M
Ohmyhome Limited	0M

Beijing Centergate Technologies (holding) Co., Ltd.

Beijing Centergate Technologies (holding) Co., Ltd. Competitors List

Main competitors